Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ TPX2 Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA316832
Description
Suggested positive control: antigen standard for TPX2 (transient overexpression lysate).
The protein encoded by this gene is found in the nucleolus and is similar to that of a family of genes on the Y-chromosome. This gene is intronless. Defects in this gene are a cause of sudden infant death with dysgenesis of the testes syndrome (SIDDT).
Specifications
TPX2 | |
Polyclonal | |
Unconjugated | |
Tpx2 | |
2610005B21Rik; C20orf1; C20orf2; Differentially expressed in cancerous and non-cancerous lung cells 2; differentially expressed in lung cells; DIL2; DIL-2; FLS353; GD: HCA519; GD:C20orf1; HCA519; HCTP4; Hepatocellular carcinoma-associated antigen 519; hepatocellular carcinoma-associated antigen 90; p100; preferentially expressed in colorectal cancer; protein fls353; REPP86; restricted expression proliferation associated protein 100; restricted expression proliferation-associated protein 100; Targeting protein for Xklp2; TPX 2; Tpx2; TPX2 microtubule nucleation factor; TPX2, microtubule nucleation factor; TPX2, microtubule-associated; TPX2, microtubule-associated protein homolog; TPX2, microtubule-associated protein homolog (Xenopus laevis); TPX2, microtubule-associated, homolog | |
Rabbit | |
100 μL | |
Primary | |
Human, Mouse, Rat, Pig, Mammalia | |
Antibody | |
IgG |
Flow Cytometry, Immunoprecipitation, Western Blot, Immunocytochemistry | |
Conc. Not Determined | |
whole serum with no preservative | |
A2APB8, Q9ULW0 | |
Tpx2 | |
Recombinant segment of the C-terminal domain of the human protein. | |
RUO | |
100525546, 22974, 311546, 72119 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction